Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study
Authors:
Open Access
- 9 May 2018
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (7) , 1017-1026
Abstract
Purpose Chlorhexidine oral care is widely used in critically and non-critically ill hospitalized patients to maintain oral health. We investigated the effect of chlorhexidine oral care on mortality in a general hospitalized population. Methods In this single-center, retrospective, hospital-wide, observational cohort study we included adult hospitalized patients (2012–2014). Mortality associated with chlorhexidine oral care was assessed by logistic regression analysis. A threshold cumulative dose of 300 mg served as a dichotomic proxy for chlorhexidine exposure. We adjusted for demographics, diagnostic category, and risk of mortality expressed in four categories (minor, moderate, major, and extreme). Results The study cohort included 82,274 patients of which 11,133 (14%) received chlorhexidine oral care. Low-level exposure to chlorhexidine oral care (≤ 300 mg) was associated with increased risk of death [odds ratio (OR) 2.61; 95% confidence interval (CI) 2.32–2.92]. This association was stronger among patients with a lower risk of death: OR 5.50 (95% CI 4.51–6.71) with minor/moderate risk, OR 2.33 (95% CI 1.96–2.78) with a major risk, and a not significant OR 1.13 (95% CI 0.90–1.41) with an extreme risk of mortality. Similar observations were made for high-level exposure (> 300 mg). No harmful effect was observed in ventilated and non-ventilated ICU patients. Increased risk of death was observed in patients who did not receive mechanical ventilation and were not admitted to ICUs. The adjusted number of patients needed to be exposed to result in one additional fatality case was 47.1 (95% CI 45.2–49.1). Conclusions These data argue against the indiscriminate widespread use of chlorhexidine oral care in hospitalized patients, in the absence of proven benefit in specific populations.Keywords
This publication has 32 references indexed in Scilit:
- Prevalence, Risk Factors, and Mortality for Ventilator-Associated Pneumonia in Middle-Aged, Old, and Very Old Critically Ill Patients*Critical Care Medicine, 2014
- Acute pulmonary toxic effects of chlorhexidine (CHX) following an intratracheal instillation in ratsHuman & Experimental Toxicology, 2011
- New Issues and Controversies in the Prevention of Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg?British Journal of Anaesthesia, 2009
- Ventilator-associated pneumonia and mortality: A systematic review of observational studies*Critical Care Medicine, 2009
- Anaphylaxis to the chlorhexidine component of Instillagel®: a case seriesBritish Journal of Anaesthesia, 2008
- The impact of ventilator-associated pneumonia on the Canadian health care systemJournal of Critical Care, 2008
- Evidence on measures for the prevention of ventilator-associated pneumoniaEuropean Respiratory Journal, 2007
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Calculating the “number needed to be exposed” with adjustment for confounding variables in epidemiological studiesJournal of Clinical Epidemiology, 2002